Pancreatic Cancer Research

ResearcherKawasaki Medical SchoolActive in the last 2 years

Koji Yoshida

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5103525207. Sources: OpenAlex.

Their work

Papers
7 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
38
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: none · 2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper · 2024: 1 paper · 2025: 1 paper · 2026: 2 papers

Papers 7

  1. Clinical characteristics and prognosis of pancreatic ductal adenocarcinoma detected by health checkups versus symptomatic presentation: a retrospective compara… Co-author DOI 10.1038/s41598-026-67871-6↗
  2. Comparative Study of Pathological and Imaging Findings in High-Grade Pancreatic Intraepithelial Neoplasia: A Multicenter Analysis by the Japan Study Group on E… Co-author DOI 10.1097/mpa.0000000000002710↗
  3. Noninvasive detection of pancreatic ductal adenocarcinoma in high-risk patients using miRNA from urinary extracellular vesicles. Last author DOI 10.3389/fonc.2025.1682072↗
  4. A noninvasive urinary microRNA-based assay for the detection of pancreatic cancer from early to late stages: a case control study. Co-author DOI 10.1016/j.eclinm.2024.102936↗
  5. Pancreatic ductal adenocarcinoma with acinar-to-ductal metaplasia-like cancer cells shows increased cellular proliferation. First author DOI 10.1016/j.pan.2023.08.007↗
  6. Multicenter study of early pancreatic cancer in Japan. Co-author DOI 10.1016/j.pan.2017.11.007↗
  7. Fibroblast activation protein-α-expressing fibroblasts promote the progression of pancreatic ductal adenocarcinoma. Co-author DOI 10.1186/s12876-015-0340-0↗

Closest collaborators

The 25 strongest of 38 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Tomoya Kawase · 3 shared papers, 2015–2025 · strength 0.38
  2. Shogo Baba · 2 shared papers, 2024–2025 · strength 0.34
  3. Tomoyuki Satake · 2 shared papers, 2024–2025 · strength 0.34
  4. Johji Imura · 2 shared papers, 2024–2025 · strength 0.34
  5. Hiroshi Kurahara · 2 shared papers, 2024–2025 · strength 0.34
  6. Hideyuki Oi · 2 shared papers, 2024–2025 · strength 0.34
  7. Hiroshi Nishihara · 2 shared papers, 2024–2025 · strength 0.34
  8. Atsushi Kanno · 2 shared papers, 2018–2026 · strength 0.29
  9. Mamoru Takenaka · 2 shared papers, 2018–2026 · strength 0.29
  10. Takao Ohtsuka · 2 shared papers, 2018–2026 · strength 0.29
  11. Keiji Hanada · 2 shared papers, 2018–2026 · strength 0.29
  12. Akio Yanagisawa · 2 shared papers, 2018–2026 · strength 0.29
  13. Toru Furukawa · 2 shared papers, 2018–2026 · strength 0.29
  14. Masayuki Kitano · 2 shared papers, 2018–2026 · strength 0.29
  15. Tomoki Yamatsuji · 1 shared paper, 2026 · strength 0.24
  16. Tomohiro Tanikawa · 1 shared paper, 2026 · strength 0.24
  17. Ken Haruma · 1 shared paper, 2026 · strength 0.24
  18. Minoru Fujita · 1 shared paper, 2026 · strength 0.24
  19. Hirofumi Kawamoto · 1 shared paper, 2026 · strength 0.24
  20. Yukiko Takayama · 1 shared paper, 2026 · strength 0.22
  21. Reiko Ashida · 1 shared paper, 2026 · strength 0.22
  22. Yasutaka Ishii · 1 shared paper, 2026 · strength 0.22
  23. Noboru Ideno · 1 shared paper, 2026 · strength 0.22
  24. Shujiro Yazumi · 1 shared paper, 2026 · strength 0.22
  25. Masao Tanaka · 1 shared paper, 2026 · strength 0.22

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.